Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Evaluation of conventional imaging performance in a research whole-body CT system with a photon-counting detector array
Yu, Zhicong , Jorgensen, Steven M., Li, Zhoubo , Gutjahr, Ralf , Chen, Baiyu , Halaweish, Ahmed F., Kappler, S. , Yu, Lifeng , Ritman, Erik L., Leng, Shuai , Yu, Lifeng , McCollough, Cynthia H.

Physics in Medicine & Biology | February 2, 2016 | Volume: 61 | Issue: 4 | Pages: 1572-1595

10.1088/0031-9155/61/4/1572 | PMID 26835839 Get It

Abstract This study evaluated the conventional imaging performance of a research whole-body photon-counting CT system and investigated its feasibility for imaging using clinically realistic levels of x-ray photon flux. This research system was built on the platform of a 2nd generation dual-source CT system: one source coupled to an energy integrating detector (EID) and the other coupled to a photon-counting detector (PCD). Phantom studies were conducted to measure CT number accuracy and uniformity for water, CT number energy dependency for high-Z materials, spatial resolution, noise, and contrast-to-noise ratio. The results from the EID and PCD subsystems were compared. The impact of high photon flux, such as pulse pile-up, was assessed by studying the noise-to-tube-current relationship using a neonate water phantom and high x-ray photon flux. Finally, clinical feasibility of the PCD subsystem was investigated using anthropomorphic phantoms, a cadaveric head, and a whole-body cadaver, which were scanned at dose levels equivalent to or higher than those used clinically. Phantom measurements demonstrated that the PCD subsystem provided comparable image quality to the EID subsystem, except that the PCD subsystem provided slightly better longitudinal spatial resolution and about 25% improvement in contrast-to-noise ratio for iodine. The impact of high photon flux was found to be negligible for the PCD subsystem: only subtle high-flux effects were noticed for tube currents higher than 300 mA in images of the neonate water phantom. Results of the anthropomorphic phantom and cadaver scans demonstrated comparable image quality between the EID and PCD subsystems. There were no noticeable ring, streaking, or cupping/capping artifacts in the PCD images. In addition, the PCD subsystem provided spectral information. Our experiments demonstrated that the research whole-body photon-counting CT system is capable of providing clinical image quality at clinically realistic levels of x-ray photon flux.
Analysis of fluid movement in skeletal muscle using fluorescent microspheres
Evertz, Loribeth Q., Greising, Sarah M. , Morrow, Duane A., Sieck, Gary C. , Kaufman, Kenton R. , Sieck, Gary , Kaufman, Kenton R

Muscle & Nerve | February 2, 2016 | Volume: 54 | Issue: 3 | Pages: 444-450

10.1002/mus.25063 | PMID 26833456 Get It

ABSTRACTIntroductionRegional variability in interstitial fluid pressure confounds use of intramuscular pressure measurement to assess muscle force. It is hypothesized that interstitial flow is dependent on intramuscular pressure. The goal of this study was to assess the feasibility of using fluorescent microspheres to evaluate movement of interstitial fluid in skeletal muscle.MethodsTwo diameters of fluorescent microspheres were injected into the rat tibialis anterior during both static (n = 6) and passively lengthened (10% strain) experimental conditions (n = 6). Microsphere dispersion was evaluated using confocal imaging of transverse muscle sections.ResultsFluorescent microspheres tracked interstitial fluid while not penetrating the muscle fiber. When compared with the static condition, significantly greater dispersion (P = 0.003) was seen with passively lengthened conditions (17 ± 9% vs. 31 ± 7%, respectively). Dispersion did not differ for the 2 microsphere sizes (P = 0.811).ConclusionsFluorescent microspheres track movement of interstitial fluid, and dispersion is dependent on passive lengthening. Muscle Nerve 54: 444–450, 2016
Development of Liposomal Formulation for Delivering Anticancer Drug to Breast Cancer Stem-Cell-Like Cells and its Pharmacokinetics in an Animal Model
Ahmad, Ajaz , Mondal, Sujan Kumar , Banerjee‬‬‬‬‬‬‬‬‬, Rintu , Alkharfy, Khalid M. , Mukhopadhyay, Debabrata , Banerjee, Rajkumar

Molecular Pharmaceutics | February 2, 2016 | Volume: 13 | Issue: 3 | Pages: 1081-1088

10.1021/acs.molpharmaceut.5b00900 | PMID 26832839 Get It

A targeted genetic association study of epithelial ovarian cancer susceptibility
Earp, Madalene A. , Winham, Stacey J. , Sicotte, Hugues , Chien, Jeremy , Goodman, Marc T. , Levine, Douglas A. , Monteiro, Álvaro N.A. , Ness, Roberta B., Pearce, Celeste Leigh, Rossing, Mary Anne, Tworoger, Shelley S. , Wentzensen, Nicolas , Bisogna, Maria, Brinton, Louise A. , Brooks‐Wilson, Angela , Carney, Michael E. , Cunningham, Julie M. , Edwards, Robert P., Fogarty, Zachary C. , Iversen, Edwin S., Kraft, Peter , Le, Nhu D. , Lin, Hui‐Yi , Lissowska, Jolanta , Moysich, Kirsten B. , Olson, Sara H. , Pike, Malcolm C. , Rider, David N., Terry, Kathryn L. , Thompson, Pamela J., Vierkant, Robert A. , Vitonis, Allison F., Wu, Anna H. , Phelan, Catherine M., Schildkraut, Joellen M. , Chen, Y. Ann , Sellers, Thomas A. , Goode, Ellen L. , Earp, Madalene, Larson, Nicholas, Larson, Nicholas B. , Permuth, Jennifer B. , Anton‐Culver, Hoda , Bandera, Elisa V. , Berchuck, Andrew , Cook, Linda S. , Cramer, Daniel W. , Doherty, Jennifer A. , Larson, Melissa C. , Modugno, Francesmary , Poole, Elizabeth M. , Berg, David Van Den , Wilkens, Lynne R. , Yang, Hannah , Ziogas, Argyrios , Fridley, Brooke L. , Winham, Stacey J , Tworoger, Shelley S , Vierkant, Robert A , Chien, Jeremey , Monteiro, Alvaro N , Moysich, Kirsten , Lissowska, Jolanta , Brooks-Wilson, Angela R , Lin, Hui-Yi , Fogarty, Zachary C , Kraft, Peter , Goodman, Marc T

Oncotarget | February 2, 2016 | Volume: 7 | Issue: 7 | Pages: 7381-7389

10.18632/oncotarget.7121 | PMID 26848776 Get It

Three-Day-Old Boy With Palmar Pustules
Oza, Vikash S. , Asch, Sarah , Mathes, Erin F.

JAMA Pediatrics | February 2, 2016 | Volume: 170 | Issue: 2 | Pages: 171

10.1001/jamapediatrics.2015.1996 | PMID 26830870 Get It

Diagnosing Testicular Torsion before Urological Consultation and Imaging: Validation of the TWIST Score
Sheth, Kunj , Keays, Mélise , Grimsby, Gwen M. , Granberg, Candace F. , Menon, Vani S. , DaJusta, Daniel , Ostrov, Lauren , Hill, Martinez, Sanchez, Emma, Kuppermann, David , Harrison, Clanton B., Jacobs, Micah A. , Huang, Rong , Burgu, Berk , Hennes, Halim , Schlomer, Bruce J., Baker, Linda A.

Journal of Urology | February 2, 2016 | Volume: 195 | Issue: 6 | Pages: 1870-1876

10.1016/j.juro.2016.01.101 | PMID 26835833 Get It

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma
Choueiri, Toni K. , Fay, André P. , Velasco, Guillermo de , Tyburczy, Magdalena E. , Hamieh, Lana , Albigès, Laurence , Ho, Thai H. , Song, Jiaxi , Pignon, Jean‐Christophe , Barrios, Pablo M. , Michaelson, M. Dror , Krajewski, Katherine M. , Porta, Camillo , Pal, Sumanta K. , Heng, Daniel Y.C., Gray, Kathryn P. , Kwiatkowski, David J. , Rini, Brian I. , Thorner, Aaron R. , Agarwal, Neeraj , Van Allen, Eliezer M , Bellmunt, Joaquim , McDermott, David F. , Signoretti, Sabina , Ho, Thai , Choueiri, Toni K

Clinical Cancer Research | February 1, 2016 | Volume: 22 | Issue: 10 | Pages: 2445-2452

10.1158/1078-0432.ccr-15-2631 | PMID 26831717 Get It

Abstract Purpose: We examined the hypothesis that mutations in mTOR pathway genes are associated with response to rapalogs in metastatic renal cell carcinoma (mRCC). Experimental Design: We studied a cohort of mRCC patients who were treated with mTOR inhibitors with distinct clinical outcomes. Tumor DNA from 79 subjects was successfully analyzed for mutations using targeted next-generation sequencing of 560 cancer genes. Responders were defined as those with partial response (PR) by RECIST v1.0 or stable disease with any tumor shrinkage for 6 months or longer. Nonresponders were defined as those with disease progression during the first 3 months of therapy. Fisher exact test assessed the association between mutation status in mTOR pathway genes and treatment response. Results: Mutations in MTOR, TSC1, or TSC2 were more common in responders, 12 (28%) of 43, than nonresponders, 4 (11%) of 36 (P = 0.06). Mutations in TSC1 or TSC2 alone were also more common in responders, 9 (21%), than nonresponders, 2(6%), (P = 0.05). Furthermore, 5 (42%) of 12 subjects with PR had mutations in MTOR, TSC1, or TSC2 compared with 4 (11%) of 36 nonresponders (P = 0.03). Eight additional non-mTOR pathway genes were found to be mutated in at least 4 of 79 tumors (5%); none were associated positively with response. Conclusions: In this cohort of mRCC patients, mutations in MTOR, TSC1, or TSC2 were more common in patients who experienced clinical benefit from rapalogs than in those who progressed. However, a substantial fraction of responders (24 of 43, 56%) had no mTOR pathway mutation identified. Clin Cancer Res; 22(10); 2445–52. ©2016 AACR. See related commentary by Voss and Hsieh, p. 2320
Education Considerations: Communication Curricula, Simulated Resuscitation, and Duty Hour Restrictions
DeMartino, Erin S. , Kelm, Diana J. , Srivali, Narat , Ramar, Kannan , Srivali, Narat

American Journal of Respiratory and Critical Care Medicine | February 1, 2016 | Volume: 193 | Issue: 7 | Pages: 801-803

10.1164/rccm.201510-2012rr | PMID 26829354 Get It

Secreted Brain-Derived Neurotrophic Factor and Asthma Severity
Wang, Shengyu , Sathish, Venkatachalem , Freeman, Michelle, Prakash, Y. S. , Thompson, Michael A. , Pabelick, Christina M. , Prakash, Y S , Sathish, Venkatachalem

American Journal of Respiratory Cell and Molecular Biology | February 1, 2016 | Volume: 54 | Issue: 2 | Pages: 297-297

10.1165/rcmb.2015-0265le | PMID 26829500 Get It